Jens T. Wuerfel

Basel, BS, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 153 publications

Efficacy and Safety of Patients With Relapsing Multiple Sclerosis Switching to Ocrelizumab Due to Suboptimal Treatment Response: Results of the 4-Year CASTING-LIBERTO Trial.

Efficacy and Safety of Patients With Relapsing Multiple Sclerosis Switching to Ocrelizumab Due to Suboptimal Treatment Response: Results of the 4-Year CASTING-LIBERTO Trial.

Journal: European journal of neurology

Published: November 11, 2025

Microstructure-informed deep learning improves thalamic atrophy segmentation and clinical associations in multiple sclerosis and related neuroimmunological diseases.

Microstructure-informed deep learning improves thalamic atrophy segmentation and clinical associations in multiple sclerosis and related neuroimmunological diseases.

Journal: NeuroImage. Clinical

Published: October 30, 2025

Federated learning for lesion segmentation in multiple sclerosis: a real-world multi-center feasibility study.

Federated learning for lesion segmentation in multiple sclerosis: a real-world multi-center feasibility study.

Journal: Frontiers in neurology

Published: May 27, 2025

Detecting New Lesions Using a Large Language Model: Applications in Real-World Multiple Sclerosis Datasets.

Detecting New Lesions Using a Large Language Model: Applications in Real-World Multiple Sclerosis Datasets.

Journal: Annals of neurology

Published: January 20, 2025

Ocrelizumab in Early-Stage Relapsing-Remitting Multiple Sclerosis: The Phase IIIb ENSEMBLE 4-Year, Single-Arm, Open-Label Trial.

Ocrelizumab in Early-Stage Relapsing-Remitting Multiple Sclerosis: The Phase IIIb ENSEMBLE 4-Year, Single-Arm, Open-Label Trial.

Journal: Neurology

Published: December 03, 2024

Ponesimod as add-on treatment in patients with active relapsing multiple sclerosis under dimethyl fumarate (POINT): A phase 3, randomized, placebo-controlled clinical trial.

Ponesimod as add-on treatment in patients with active relapsing multiple sclerosis under dimethyl fumarate (POINT): A phase 3, randomized, placebo-controlled clinical trial.

Journal: Multiple sclerosis and related disorders

Published: November 28, 2024

Aquaporin-4 Immunoglobulin G-seropositive Neuromyelitis Optica Spectrum Disorder MRI Characteristics: Data Analysis from the International Real-World PAMRINO Study Cohort.

Aquaporin-4 Immunoglobulin G-seropositive Neuromyelitis Optica Spectrum Disorder MRI Characteristics: Data Analysis from the International Real-World PAMRINO Study Cohort.

Journal: Radiology

Published: November 12, 2024

Biomarker, Imaging, and Clinical Factors Associated With Overt and Covert Stroke in Patients With Atrial Fibrillation.

Biomarker, Imaging, and Clinical Factors Associated With Overt and Covert Stroke in Patients With Atrial Fibrillation.

Journal: Stroke

Published: August 07, 2023

SAkuraBONSAI: Protocol design of a novel, prospective study to explore clinical, imaging, and biomarker outcomes in patients with AQP4-IgG-seropositive neuromyelitis optica spectrum disorder receiving open-label satralizumab.

SAkuraBONSAI: Protocol design of a novel, prospective study to explore clinical, imaging, and biomarker outcomes in patients with AQP4-IgG-seropositive neuromyelitis optica spectrum disorder receiving open-label satralizumab.

Journal: Frontiers in neurology

Published: December 02, 2022

Optical coherence tomography reflects clinically relevant gray matter damage in patients with multiple sclerosis.

Optical coherence tomography reflects clinically relevant gray matter damage in patients with multiple sclerosis.

Journal: Journal of neurology

Published: November 13, 2022

A Multicenter Longitudinal MRI Study Assessing LeMan-PV Software Accuracy in the Detection of White Matter Lesions in Multiple Sclerosis Patients.

A Multicenter Longitudinal MRI Study Assessing LeMan-PV Software Accuracy in the Detection of White Matter Lesions in Multiple Sclerosis Patients.

Journal: Journal of magnetic resonance imaging : JMRI

Published: October 24, 2022

Physical activity and brain health in patients with atrial fibrillation.

Physical activity and brain health in patients with atrial fibrillation.

Journal: European journal of neurology

Published: October 10, 2022

Showing 1-12 of 153

Last Updated: 09/26/2026